4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-091733
President & CEO sold 5,466 shares at $17.92 ($97,974)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Warmuth Markus · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-02 | Sale : show line 1 in the form 10b5-1 | −5,466 | $17.92 | $97,974 | 613,471 | D |
| Open-market sales · 5,466 sh · avg $17.92 · $97,974 | ||||||
Loading xslF345X05/ownership.xml…